However, it has been shown that low expression of mGluR3 correlates with a better survival rate in GBM [192], and that the blockade of mGluR2/3 activity reduces U87MG growth halting cell cycle progression [193] and reduces the proliferation of primary cultures of GBM [194]. Here, GRM2 is linked to glioblastoma.